Two-decade Pfizer mission pays off for Guggenheim's deal king
November 26, 2015 at 13:57 PM EST
* Guggenheim named Pfizer's lead adviser on $160 bln Allergan deal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.